Advertisement
    Yesterday
    In the last 7 days
    First confirmed case of Mpox reported The Express Tribune05:30 23-Mar-25
    Pakistan confirms 2nd mpox case in 2025 The Times of India01:47 23-Mar-25
    Pak confirms 2nd mpox case in 2025 AniNews.in01:09 23-Mar-25
    First mpox case registered in Karachi Business Recorder, Pakistan00:40 23-Mar-25
    CHP investigates confirmed Mpox case The Government of Hong Kong Special Administrative Region (Press Release)11:08 21-Mar-25
    New data on Mpox vaccine effectiveness ScienceDaily22:02 20-Mar-25
    In the last month
    UK no longer deems clade 1 mpox 'high consequence' Center for Infectious Disease Research and Policy19:58 19-Mar-25
    Estimates: Jynneos mpox vaccine 84% and 35% effective in people without, with HIV Center for Infectious Disease Research and Policy19:28 19-Mar-25
    Charité study yields new data on Mpox vaccine effectiveness The Charité (Press Release)09:40 19-Mar-25
    Mpox case in Khyber not locally transmitted The Express Tribune04:41 17-Mar-25
    Mpox vaccines are beginning to roll out in Uganda Gavi, the Vaccine Alliance14:39 14-Mar-25
    Tecovirimat is safe but ineffective as treatment for clade II mpox National Institutes of Health15:46 12-Mar-25
    Actg Presents Data from Mpox Study stomp at Croi GlobeNewswire (Press Release)15:35 12-Mar-25
    Sunderland among twelve new mpox vaccination sites across England South Tyneside and Sunderland NHS Foundation Trust (Press Release)11:40 12-Mar-25
    Tanzania confirms two mpox cases The Citizen, Tanzania16:39 10-Mar-25
    Fighting Multiple Outbreaks in Zambia’s Copperbelt Africa CDC (Press Release)15:17 9-Mar-25
    Two more monkeypox cases reported in K-P The Express Tribune05:13 8-Mar-25
    Mpox Testing Rate Plummets to 17% in DRC Health Policy Watch16:43 6-Mar-25
    New faster-spreading Mpox strain discovered in Africa The Irish Independent02:33 4-Mar-25
    South Africa reports 3 new cases of mpox People's Daily06:28 1-Mar-25
    WHO extends mpox emergency as more transmissible clade 1a variant identified in DR Congo Center for Infectious Disease Research and Policy21:42 27-Feb-25
    Mpox still a health emergency, says WHO The Korea Times13:15 27-Feb-25
    US aid freeze hampers Africa’s fight against Mpox Research Professional News08:23 27-Feb-25
    view more headlines
    26 Mar 06:33

    About our Mpox news

    Latest news on mpox (monkeypox), providing comprehensive coverage of outbreaks, prevention measures, vaccination efforts, and global health responses to this viral disease.

    Mpox, formerly known as monkeypox, is a viral infection caused by Orthopoxvirus monkeypox. The disease has gained global attention since the unprecedented 2022-2023 outbreak, which saw over 93,000 cases reported worldwide. Mpox typically causes a rash, fever, and swollen lymph nodes, with symptoms lasting 2-4 weeks.

    As of 19 August 2024, health authorities are grappling with a new outbreak of the more virulent clade I mpox in Central Africa. The World Health Organization (WHO) declared this outbreak a Public Health Emergency of International Concern on 14 August, citing its rapid spread and high case fatality rate of around 5%. The outbreak has now reached several African countries, including the Democratic Republic of Congo, Republic of Congo, Uganda, Kenya, Rwanda, and Burundi. Alarmingly, the first case outside Africa was reported in Sweden on 15 August, raising concerns about potential global spread.

    The current outbreak disproportionately affects children, who account for an estimated 64% of cases and 85% of fatalities. This has prompted urgent calls for increased vaccination efforts and public health measures. Meanwhile, communities in affected areas are mobilising to raise awareness and support those impacted by the disease.

    Mpox has a complex history, with the first human case identified in 1970 in the Democratic Republic of Congo. Since then, sporadic outbreaks have occurred in Central and West Africa. The 2022-2023 global outbreak marked a significant shift, as it was the first time widespread community transmission occurred outside Africa. This led to increased research efforts and the development of new prevention and treatment strategies.

    As the situation continues to evolve, staying informed about mpox developments is crucial. Our NewsNow feed provides up-to-date, comprehensive coverage from reliable sources, including the WHO, national health agencies, and leading research institutions. Whether you're a healthcare professional, policymaker, or concerned citizen, our feed ensures you have the latest information on this important global health issue.


    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.